BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
5/14/2026 9:17:08 AM | Browse: 6 | Download: 23
 |
Received |
|
2025-11-06 07:40 |
|
Peer-Review Started |
|
2025-11-06 08:18 |
|
First Decision by Editorial Office Director |
|
2025-12-04 09:25 |
|
Return for Revision |
|
2025-12-05 06:19 |
|
Revised |
|
2025-12-18 20:37 |
|
Publication Fee Transferred |
|
2025-12-25 14:50 |
|
Second Decision by Editor |
|
2026-02-09 02:47 |
 |
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2026-02-09 07:20 |
|
Articles in Press |
|
2026-02-09 07:20 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2026-04-28 00:16 |
|
Publish the Manuscript Online |
|
2026-05-14 09:17 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2026. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Basic Study |
| Article Title |
ELF3 emerges as a novel prognostic indicator implicated in gastric cancer progression and correlated with unfavorable clinical outcomes
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Zong-Sheng Sun, Chang-Lei Li, Han-Hui Jing, Zheng-Zhao Wang and Long-Bo Zheng |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Long-Bo Zheng, MD, /, The Affiliated Hospital of Qingdao University, No. 1677 Wutai Street, Huangdao District, Qingdao 266000, Shandong Province, China. zhenglongbo2021@qdu.edu.cn |
| Key Words |
E74-like ETS transcription factor 3; Stomach adenocarcinoma; Tumor; Prognosis; Immune infiltration; Biomarker |
| Core Tip |
E74-like ETS transcription factor 3 (ELF3) is an epithelial transcription factor whose role in stomach adenocarcinoma (STAD) has been unclear. Integrating multi-database analyses with a 100-patient clinical cohort, we show that ELF3 is upregulated in STAD, independently predicts survival, and associates with immune-cell and chemokine infiltration. High ELF3 expression co-occurs with an immunosuppressive tumor microenvironment, suggesting a mechanism for disease progression. These findings position ELF3 as a practical prognostic biomarker and a rational therapeutic target to modulate antitumor immunity in STAD. |
| Publish Date |
2026-05-14 09:17 |
| Citation |
Sun ZS, Li CL, Jing HH, Wang ZZ, Zheng LB. ELF3 emerges as a novel prognostic indicator implicated in gastric cancer progression and correlated with unfavorable clinical outcomes. World J Gastrointest Oncol 2026; 18(5): 116163 |
| URL |
https://www.wjgnet.com/1948-5204/full/v18/i5/116163.htm |
| DOI |
https://dx.doi.org/10.4251/wjgo.v18.i5.116163 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
